Clinical Trials
8 trialsNCT07243899 2025-11-24
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Shanghai Zhongshan Hospital
Completed
NCT04871997 2022-10-21
A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)
Tongji Hospital
Completed
NCT05034445 2021-09-05
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer
Guangzhou Institute of Respiratory Disease
Completed
NCT04858204 2021-04-26
IMMUNOBZH
University Hospital, Brest
Completed
NCT01859650 2019-09-26
HeXeRT
Sheffield Teaching Hospitals NHS Foundation Trust
Completed
NCT02029222 2019-09-04
Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.
Maastricht Radiation Oncology
Completed
NCT03073902 2018-12-28
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
Xinqiao Hospital of Chongqing
Completed
NCT03609918 2018-08-07
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
Tianjin Medical University Cancer Institute and Hospital
Completed